论文部分内容阅读
目的研究MRI新技术在肺癌靶向治疗中所产生的影响,分析其应用价值。方法选取医院在2010年6月-2013年6月收治的62例肺癌患者的临床资料,所有患者均实施靶向治疗,随机将患者分为观察组和对照组各31例,观察组在患者实施靶向治疗前后行MRI新技术检查,对照组在患者实施靶向治疗前后行CT检查,比较2组患者的检查结果,分析MRI新技术在肺癌靶向治疗中的具体应用价值。结果观察组总缓解率为93.5%,对照组的总缓解率为90.3%。2组比较差异无统计学意义(P>0.05)。结论 MRI新技术在能够被应用于肺癌靶向治疗中,且可以取得显著疗效,具有良好的应用价值,值得临床推广应用。
Objective To study the effect of MRI in targeted therapy of lung cancer and analyze its application value. Methods The clinical data of 62 patients with lung cancer who were admitted to our hospital from June 2010 to June 2013 were selected. All patients were treated with targeted therapy. The patients were randomly divided into observation group (31 cases) and control group (31 cases). Patients in observation group The new MRI examination before and after targeted therapy was performed. The patients in the control group underwent CT examination before and after the targeted therapy. The results of the two groups of patients were compared and the specific value of the new MRI technique in the targeted therapy of lung cancer was analyzed. Results The total remission rate was 93.5% in the observation group and 90.3% in the control group. There was no significant difference between the two groups (P> 0.05). Conclusion The new MRI technique can be applied in the targeted therapy of lung cancer and can achieve significant curative effect. It has a good application value and is worthy of clinical application.